Division of Gastroenterology, Wuhan Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.
Chin Med J (Engl). 2009 Dec 20;122(24):3003-6.
Octride was the main method for the treatment of esophageal variceal bleeding (EVB). The aim of this study was to compare the cost-effect and safety between esophageal variceal ligation (EVL) plus octride and octride alone in acute esophageal bleeding.
A total of 101 cirrhotic patients with EVB were involved in this study and received emergency EVL + octride (EVL group) or only octride therapy randomly. The cost, efficacy and safety were analyzed and compared between the two groups.
Among 51 patients in EVL group, 5 (10%) patients failed. Among 50 patients in the octride treatment group, 13 patients (26%) failed. The difference was significant (P < 0.05). The average blood transfusion volume was (2.4 +/- 2.2) units in the EVL group and (6.4 +/- 3.4) units in the octride treatment group (P < 0.05). Hospital stay was (7.4 +/- 1.3) days in the EVL group and (11.4 +/- 3.3) days in the octride treatment group (P < 0.05). The average hospital cost was (10 983 +/- 1147) yuan in the EVL group and (13 921 +/- 2107) yuan in the octride treatment group (P < 0.05).
Emergency endoscopic ligation plus octride is superior to octride alone in the treatment of acute EVB with lower cost and higher efficacy with enough safety.
奥曲肽是治疗食管胃静脉曲张出血(EVB)的主要方法。本研究旨在比较食管静脉曲张结扎术(EVL)加奥曲肽与奥曲肽单独治疗急性食管出血的成本效益和安全性。
本研究共纳入 101 例肝硬化合并 EVB 患者,随机接受紧急 EVL+奥曲肽(EVL 组)或仅奥曲肽治疗。分析比较两组的成本、疗效和安全性。
EVL 组 51 例患者中,5 例(10%)失败;奥曲肽治疗组 50 例患者中,13 例(26%)失败。差异有统计学意义(P<0.05)。EVL 组平均输血量为(2.4±2.2)单位,奥曲肽治疗组为(6.4±3.4)单位(P<0.05)。EVL 组住院时间为(7.4±1.3)天,奥曲肽治疗组为(11.4±3.3)天(P<0.05)。EVL 组平均住院费用为(10983±1147)元,奥曲肽治疗组为(13921±2107)元(P<0.05)。
在治疗急性 EVB 时,紧急内镜结扎加奥曲肽比奥曲肽单独治疗具有更低的成本和更高的疗效,且安全性足够。